Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 105 | 163 | 53 | 92 | 74 |
| Cost of Goods | 36 | 60 | 40 | 34 | 29 |
| Gross Profit | 69 | 103 | 13 | 59 | 45 |
| Operating Expenses | 622 | 607 | 1,114 | 571 | 1,077 |
| Operating Income | -517 | -445 | -1,062 | -479 | -1,003 |
| Interest Expense | 97 | 78 | 43 | 34 | 38 |
| Other Income | 103 | -13 | 5 | 3 | 0 |
| Pre-tax Income | -511 | -535 | -1,100 | -511 | -1,041 |
| Net Income Continuous | -511 | -535 | -1,100 | -511 | -1,041 |
| Net Income | $-511 | $-535 | $-1,100 | $-511 | $-1,041 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.15 | -0.07 | -0.14 |
| EPS Basic Continuous Ops | -0.06 | -0.06 | -0.15 | -0.07 | -0.14 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.15 | -0.07 | -0.14 |
| EPS Diluted Continuous Ops | -0.06 | -0.06 | -0.15 | -0.07 | -0.14 |
| EBITDA(a) | $-320 | $-368 | $-733 | $-442 | $-966 |